A low-molecular-weight heparin-coated doxorubicin-liposome for the prevention of melanoma metastasis (Q38925364)

7 September 2017

A low-molecular-weight heparin-coated doxorubicin-liposome for the prevention of melanoma metastasis (English)

1 reference

7 September 2017

Yi Chen

1

1 reference

7 September 2017

Jianqing Peng

2

1 reference

7 September 2017

Miaomiao Han

3

1 reference

7 September 2017

Mezghrani Omar

4

1 reference

7 September 2017

Danrong Hu

5

1 reference

7 September 2017

Xue Ke

6

1 reference

7 September 2017

Na Lu

7

1 reference

7 September 2017

26 December 2014

1 reference

Journal of Drug Targeting

7 September 2017

1 reference

7 September 2017

23

1 reference

7 September 2017

4

1 reference

7 September 2017

335-346

1 reference

The Microenvironmental Effect in the Progression, Metastasis, and Dormancy of Breast Cancer: A Model System within Bone Marrow

7 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Dissemination and growth of cancer cells in metastatic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Inhibition of breast cancer metastasis by dual liposomes to disturb complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Effect of antihemostatic agents on experimental tumor dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Biophysics of selectin-ligand interactions in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Deadly allies: the fatal interplay between platelets and metastasizing cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Thrombosis in cancer: an update on prevention, treatment, and survival benefits of anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Differential metastasis inhibition by clinically relevant levels of heparins--correlation with selectin inhibition, not antithrombotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

The anthracycline antineoplastic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

[(186)Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Development of novel polymeric micellar drug conjugates and nano-containers with hydrolyzable core structure for doxorubicin delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Modified heparins inhibit integrin alpha(IIb)beta(3) mediated adhesion of melanoma cells to platelets in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

The attenuation of experimental lung metastasis by a bile acid acylated-heparin derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Inhibition of adhesion of human neutrophils and eosinophils to P-selectin by the sialyl Lewis antagonist TBC1269: preferential activity against neutrophil adhesion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

An arginine derivative contained nanostructure lipid carriers with pH-sensitive membranolytic capability for lysosomolytic anti-cancer drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Serum decreases the size of Metafectene-and Genejammer-DNA complexes but does not affect significantly their transfection activity in SCCVII murine squamous cell carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Mechanisms of fibroblast growth factor 2 intracellular processing: a kinetic analysis of the role of heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

VEGF, bFGF and EGF in the angiogenesis of human melanoma xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

The role of fibroblast growth factors and their receptors in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Assessment of anti-metastatic effects of anticoagulant and antiplatelet agents using animal models of experimental lung metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Antimetastatic activities of heparins and modified heparins. Experimental evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

Effects of anticoagulants on cancer: heparins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.996760

10.3109/1061186X.2014.996760

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference